The Asia-Pacific IVF Services Market was valued at $8,100.04 million in 2018 and is expected to reach $24,216.42 million by 2028, registering a CAGR of 11.6% from 2019 to 2028. IVF is a complex series of procedure used to help by fertility or avoid genetic problems and assist with the conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab The Asia-Pacific IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to a rise in infertility rate, an increase in trend of delayed pregnancies, A surge in IVF success rate, and a rise in disposable income in the region. However, complications associated with IVF treatment and lower awareness regarding IVF in some under developed regions hinders the growth of the market. Furthermore, A surge in fertility tourism, an increase in the number of fertility clinics, and growth opportunities in emerging markets make way for the development of the Asia-Pacific IVF market in the future.
Asia-Pacific presents productive opportunities for the players operating in the IVF services market, owing to its high population base, growth in knowledge about IVF treatment, low costs of the IVF treatments, Delayed pregnancy trends rise in number of infertile populations, and A surge in disposable income. In older women (more than 40 years age group), the eggs produced by the reproductive system are not fully formed for the process of fertilization. This may result in the risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in the production of healthy eggs and an increased chance of miscarriage. Thus, an increase in trend of delayed pregnancy in women is anticipated to drive the growth of the IVF services market.
The Asia-Pacific IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, the Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
BY Cycle Type
By End User
BY Country
LIST OF KEY PLAYERS PROFILED IN THE REPORT
The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.
The Asia-Pacific IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, the Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
- It offers a quantitative analysis from 2018 to 2028, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled to understand the competitive outlook of the Asia-Pacific market.
KEY MARKET SEGMENTS
BY Cycle Type
- Fresh IVF Cycles (Non-Donor)
- Thawed IVF Cycles (Non-Donor)
- Donor Egg IVF Cycles
By End User
- Fertility Clinics
- Hospitals
- Surgical centers
- Clinical research institutes
BY Country
- Asia Pacific
- Japan
- India
- China
- Australia
- New Zealand
- South Korea
- Thailand
- Singapore
- Malaysia
- Indonesia
- Philippines
- Vietnam
- Myanmar
- Rest of Asia-Pacific
LIST OF KEY PLAYERS PROFILED IN THE REPORT
The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: India Ivf Services Market, (Revenue and Number of Cycles)
Chapter 5: China Ivf Services Market, (Revenue and Number of Cycles)
Chapter 6: Japan Ivf Services Market, (Revenue and Number of Cycles)
Chapter 7: Australia Ivf Services Market, (Revenue and Number of Cycles)
Chapter 8: New Zealand Ivf Services Market, (Revenue and Number of Cycles)
Chapter 9: South Korea Ivf Services Market, (Revenue and Number of Cycles)
Chapter 10: Thailand Ivf Services Market, (Revenue and Number of Cycles)
Chapter 11: Singapore Ivf Services Market, (Revenue and Number of Cycles)
Chapter 12: Malaysia Ivf Services Market, (Revenue and Number of Cycles)
Chapter 13: Indonesia Ivf Services Market, (Revenue and Number of Cycles)
Chapter 14: Philippines Ivf Services Market, (Revenue and Number of Cycles)
Chapter 15: Vietnam Ivf Services Market, (Revenue and Number of Cycles)
Chapter 16: Myanmar Ivf Services Market (Revenue and Number of Cycles)
Chapter 17: Rest of Asia-Pacific Ivf Services Market (Revenue and Number of Cycles)
Executive Summary
According to the report titled, Asia-Pacific IVF Services Market, by Cycle Type, and End User: Opportunity Analysis and Industry Forecast, 2018-2028 the market generated $2,527 million in 2014 and is projected to reach $13,669 million by 2028, growing at a CAGR of 12.4% from 2018 to 2028.In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assisted couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and growth in disposable income in Asia-Pacific region drive the growth of the IVF services market. However, market growth is restricted by complications associated with IVF treatment, and low awareness level for IVF in some under developed regions.
Based on cycle-type, the fresh cycle (non-donor) segment is major revenue contributor and is expected to dominate the market during the forecast period.
Depending on end user, the Asia-Pacific IVF services market is dominated by the fertility clinics segment and is estimated to continue this trend during the forecast period, due to low cost of treatment and increase in number of fertility clinics.
Key Findings of the Asia-pacific IVF Services Market:
Fresh IVF cycle (non-donor) segment is expected to grow at a significant CAGR of 12.9% (in terms of value) from 2018 to 2028
Japan generated the highest revenue in the Asia-Pacific IVF services market in 2017 accounting for nearly half of the market share in 2017
Japan witnessed the highest number of IVF treatments accounting for nearly two-fifths of the total cycles in 2017 and is expected to remain so throughout the forecast period
India is expected to register the highest CAGR of 15.3% (in terms of value) throughout the forecast period
The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.
Companies Mentioned
- Apollo Hospitals Dhaka
- Australian Concept Infertility Medical Center (ACIMC)
- Bahosi Fertility Centre
- Bangkok IVF center
- Bloom Fertility and Healthcare
- Bloom Fertility Center
- Bourn Hall Fertility Center
- Bumrungrad International Hospital
- Center for Advanced Reproductive Medicine and Infertility
- CHA Fertility Center
- Chennai Fertility Center
- Cloudnine Fertility
- Damai Service Hospital
- Fatemieh Infertility Center
- Fertility Associates
- Fertility Centre Nepal (Part of Wecare Health Services
- India)
- Fertility First
- Flinders Reproductive Medicine Pty Ltd
- Genea Oxford Fertility Limited
- IHH Healthcare Berhad
- IVF NAMBA Clinic
- IVF Sri Lanka Life Plus (Pvt) Ltd
- IVF Van Hanh
- KL Fertility & Gynecology Centre
- Lanka Hospitals
- LIFE - Lahore Institute of Fertility & Endocrinology
- Lotus Fertility Clinic
- Manipal Fertility
- Maria Fertility Hospital
- MEHR IVF Clinic
- Monash IVF Wesley Hospital Auchenflower
- Morpheus Life Sciences Pvt. Ltd.
- Morula IVF
- National University Hospital
- Nepal International Fertility Centre
- Oak Medical Group/Oak Clinic
- Raffles Medical Group
- epromed
- RSUP Dr. Hasan Sadikin Bandung
- SAFE Fertility Center
- Sanno Hospital
- Saqib Fertility & IVF Center Mid City Hospital
- Shanghai Ji Ai Genetics & IVF Institute
- Shanghai
- United Family Hospital
- Southend Fertility and IVF
- Superior A.R.T Myanmar
- Thomson Medical Pte. Ltd.
- TMC Fertility Centre
- Tu Du Hospital
- Victory A.R.T. Laboratory Phils. Inc.
- Virtus Health
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 372 |
| Published | May 2020 |
| Forecast Period | 2018 - 2028 |
| Estimated Market Value ( USD | $ 8100.04 million |
| Forecasted Market Value ( USD | $ 24216.42 million |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 53 |
